Nucleic Acid Chemical Modifications

European Patent Office Patent

APP PUB NO EP-2669290-A1
SERIAL NO

13004187

Stats

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides nucleosides of formula (1) and oligonucleotides comprising at least on nucleoside of formula (2): Another aspect of the invention relates to a method of inhibiting the expression of a gene in cell, the method comprising (a) contacting and oligonucleotide of the invention with the cell; and (b) maintaining the cell from step (a) for a time sufficient to obtain degradation of the mRNA of the target gene.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ALNYLAM PHARMACEUTICALS INCUS300 THIRD STREET CAMBRIDGE MA 02142 UNITED STATES OF AMERICA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address
MANOHARAN MUTHIAH MASSACHUSETTS MASSACHUSETTS
RAJEEV KALLANTHOTTATHIL G WAYLAND MA
TAKKELLAPATI SUDHAKAR RAO CAMBRIDGE MA 02142
MATSUDA SHIGEO CAMBRIDGE MA
KELIN ALEXANDER V CAMBRIDGE MA 02142

Cited Art Landscape

Load Citation